Clinical Trial Update: A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of LY3039478 in participants with advanced or metastatic solid tumors was terminated. Results were posted on 2025-08-21.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cholangiocarcinoma
• Colon Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• LY3039478

Snippet

Sponsor: Eli Lilly and Company | Conditions: Solid Tumor, Breast Cancer | Phase 1 | Status: TERMINATED | Results posted: 2025-08-21